#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Osteosarcoma Duchenne muscular dystrophy gene carrier Congenital hypotransferrinaemia Intracranial calcification Diffuse large B-cell lymphoma refractory Extra-osseous Ewing's sarcoma Adenocarcinoma pancreas Neurodegenerative disorder Fatty acid oxidation disorder Squamous cell carcinoma of the vulva Congenital growth hormone deficiency Glomerulonephritis membranous Dupuytren's contracture Immune-mediated renal disorder Acute myeloid leukaemia (in remission) More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma recurrent – Life with Disease Andersen-Tawil syndrome Glycogen storage disease type II – Diagnostics Systemic sclerosis pulmonary – Trials in Disease Chronic granulomatous disease KBG syndrome – Trials in Disease Rhabdomyosarcoma recurrent – Basic Information Haemophagocytic lymphohistiocytosis – Diagnostics Rhabdoid tumour Synovial sarcoma metastatic – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Quercus Robur Pollen Extract GSKVX000000070965 Doxorubicin Hydrochloride Tetracosactide Finasteride Nmd670 Pioglitazone Hydrochloride Mercaptamine Dog Epithelium Extract Memantine Hydrochloride Calcium Levofolinate Mk-1200 SAT-3247 OXALATE Fostemsavir Trometamol Cldn6 Car-T Triamcinolone Hexacetonide Linsitinib Df6002 Dapagliflozin Propanediol ELTANEXOR More therapies…

    Learn about Your Condition

    CDKL5 deficiency disorder Combined immunodeficiency Paraesthesia Hydrocele Endometrial cancer recurrent Carcinoid tumour pulmonary Asthma Micrographic skin surgery Behavioural addiction Infant sedation Mitochondrial DNA depletion Osteoporosis postmenopausal Fibromyalgia Sinusitis bacterial Menopausal symptoms More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Peripheral arterial occlusive disease

  • A study comparing one month versus one year of aspirin and clopidogrel treatment in patients with chronic limb-threatening ischemia after below-the-knee vascular therapy.

    Recruiting

    3 1 1
    Investigated Diseases:
    • Peripheral artery angioplasty
    • Peripheral artery thrombosis
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • Clopidogrel
    France

  • A study to evaluate the efficacy and safety of orforglipron in patients with peripheral artery disease

    Recruiting

    3 1
    Investigated Diseases:
    • Peripheral arterial occlusive disease
    France The Netherlands Poland Slovakia

  • Study of APAC (antiplatelet, anticoagulant) treatment in patients with peripheral arterial disease and chronic limb-threatening ischemia during blood vessel restoration procedure

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • UNFRACTIONATED HEPARIN, PORCINE, CONJUGATED WITH HUMAN SERUM ALBUMIN
    • Heparin Sodium
    • Sodium Chloride
    Finland

  • Study on the Effects of TRI-001 for Patients with Chronic Limb Threatening Ischemia Due to Peripheral Arterial Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • ALLOGENEIC REGULATORY MACROPHAGES
    Germany

  • Study on the Safety of Leukocyte-Platelet Rich Fibrin for Patients with Critical Limb Ischemia

    Recruiting

    1 1 1
    Investigated Diseases:
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • FIBRIN
    Poland

  • Study on the Effects of Autologous Bone Marrow-Derived Mononuclear Cells for Patients with Diabetic Foot Syndrome and Lower Limb Ischemia

    Recruiting

    4 1 1
    Investigated Diseases:
    • Diabetic foot
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • AUTOLOGOUS BONE MARROW-DERIVED MONONUCLEAR CELLS
    Czechia
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!